Distribution of dopamine transporters in basal ganglia of cerebellar ataxic mice by [125I]RTI-121 quantitative autoradiography

Neurochemistry International

Volumn 32, Issue 1, 1998, Pages 61-68

  Strazielle, Catherine ^a,b   Lalonde, Robert ^a,c   Amdiss, Fatima ^a   Botez, Mihai I ^a,c   Hébert, Caroline ^a   Reader, Tomás A ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE LORRAINE   (France)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; DOPAMINE TRANSPORTER; IODINE 125;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BINDING AFFINITY; CELL DEGENERATION; CEREBELLAR ATAXIA; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; MESENCEPHALON; MOUSE; NEOSTRIATUM; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; VENTRAL TEGMENTUM;

ANIMALS; AUTORADIOGRAPHY; BASAL GANGLIA; CARRIER PROTEINS; CEREBELLAR ATAXIA; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HETEROZYGOTE; HOMOZYGOTE; IODINE RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, NEUROLOGIC MUTANTS; NEOSTRIATUM; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; OLFACTORY PATHWAYS; SUBSTANTIA NIGRA; TEGMENTUM MESENCEPHALI; THALAMUS; TISSUE DISTRIBUTION;

ANIMALIA; ATAXIA;

EID: 0031975691     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(97)00042-9     Document Type: Article

References (59)

1. Amara, S. G., & Kuhar, M. J. (1993). Neurotransmitter transporters: Recent progress. Ann. Rev. Neurosci., 16, 73-93.
2. 3H]GBR 12935 binding in vitro to rat striatal membranes: Labeling of the dopamine uptake complex. J. Neurochem., 48, 1887-1896.
3. Barlow, R. B. (1983). Biodata Handling with Microcomputers. Elsevier Science, Amsterdam.
4. Berciano, J. (1982). Olivopontocerebellar atrophy. A review of 117 cases. J. Neurol. Sci., 53, 253-272.
5. 125I]RTI-55: a potent ligand for dopamine transporters. Eur. J. Pharmacol., 194, 133-134.
6. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse, 12, 27-36.
7. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester. Molec. Pharmacol., 47, 779-786.
8. Bormann, J. (1989). Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol., 166, 591-592.
9. Botez, M. I., Young, S. N., Botez, T., & Pedraza, O. L. (1991). Treatment of heredo-degenerative ataxias with amantadine hydrochloride. Can. J. Neurol. Sci., 18, 307-311.
10. Botez, M. I., Botez-Marquard, T., Élie, R., Pedraza, O. L., Goyette, K., & Lalonde, R. (1996). Amantadine hydrochloride treatment in heredodegenrative ataxias: a double blind study. J. Neurol. Neurosurg. Psychiat., 61, 259-264.
11. Caddy, K. W. T., & Biscoe, T. J. (1979). Structural and quantitative studies on the normal C3H and Lurcher mutant mice. Philos. Trans. R. Soc. B, 287, 167-201.
12. Carli, M., Morissette, M., Hébert, C., Di Paolo, T., & Reader, T. A. (1997). Effects of a chronic lithium treatment on central dopamine transporters. Biochem. Pharmacol., 54, 391-397.
13. 125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography. Synapse, 12, 37-46.
14. Cox, J. A., Lysko, P. G., & Henneberry, R. C. (1989). Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: role of the voltage dependent magnesium block. Brain Res., 499, 266-272.
15. 3H]nomifensine to striatal membranes. Biochem. Pharmacol., 34, 1137-1144.
16. Duchen, L. W., & Falconer, D. S. (1964). Clinical and pathological studies of an hereditary neuropathy in mice (distonia musculorum). Brain, 87, 367-378.
17. Elsworth, J. D., Al-Tikriti, M. S., Sladek, J. R., Taylor, J. R., Innis, R. B., Redmond, D. E., & Roth, R. H. (1994). Novel radioligands for the dopamine transporter demonstrate the presence of intrastriatal nigral grafts in the MPTP-treated monkey: Correlation with improved behavioral function. Neurology, 126, 300-304.
18. Erdo, S. L., & Schaefer, M. (1991). Memantine is highly potent in protecting cortical cultures against excitotoxic death evoked by glutamate and N-methyl-D-aspartate. Eur. J. Pharmacol., 198, 215-217.
19. Fisher, R. A., & Yates, F. (1957). Statistical Tables for Biological, Agricultural and Medical Research. Oliver and Boyd, London.
20. Giros, B., Mestikawy, S. E., Godinot, N., Zheng, K., Han, H., Yang-Feng, T., & Caron, M. G. (1992). Cloning, pharmacological characterization, and chromosome assignement of the human dopamine transporter. Mol. Pharmacol., 42, 383-390.
21. Giros, B., Wang, Y.-M., Suter, S., McLeskey, S. B., Pifi, C., & Caron, M. G. (1994). Delineation of discrete domains for substrate, cocaine, and tricyclic anti-depressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem., 269, 15985-15988.
22. Green, M. C. (1981). Genetic Variations and Strains of the Laboratory Mouse. Gustav Fischer, Stuttgart..
23. Heckroth, J. A. (1994), Quantitative morphological analysis of the cerebellar nuclei in normal and lurcher mutant mice. I. Morphology an cell number. J. Comp. Neurol., 343, 173-182.
24. Iversen, L. L. (1973). Catecholamine uptake processes. Br. Med. Bull., 29, 130-135.
25. 3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol., 26, 35-44.
26. 3H]mazindol autoradiography. J. Neurosci., 5, 1513-1521.
27. Kennedy, L. T., & Hanbauer, I. (1983). Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites. J. Neurochem., 42, 172-178.
28. Kish, S. J., Robitaille, Y., Le-Awar, M., Clark, B., Schut, L., Ball, J. M., Young, L. T., Currier, R., & Shannak, K. (1992). Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy. Neurology, 42, 1573-1577.
29. 3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur. J. Pharmacol., 166, 589-590.
30. Kuhar, M. J., Sanchez-Roa, P. M., Wong, D. F., Dannals, R. F., Grigoriadis, D. E., Lew, R., & Milberger, M. (1990). Dopamine transporter: biochemistry, pharmacology and imaging. Eur. Neurol., 30 (suppl), 15-20.
31. Lane, J. D., Nadi, N. S., McBride, W. J., Aprison, M. H., & Kusano, K. (1977). Contents of serotonin, norepinephrine and dopamine of the "staggerer", "weaver" and "nervous" neurologically mutant mice. J. Neurochem., 29, 349-350.
32. Lalonde, R., Joyal, C. C., Guastavino, J. M., Côté, C. I., & Botez, M. I. (1993). Amantadine and ketamine-induced improvement of motor coordination in lurcher mutant mice. Restor. Neurol. Neurosci., 5, 367-370.
33. Lehman, A. (1974) Atlas Stéréotaxique du Cerveau de la Souris. Editions du CNRS, Paris.
34. 3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol. Pharmacol., 36, 518-524.
35. Messer, A. (1982). Amino acid changes in the mouse mutant dystonia musculorum similar to those in Friedreich's ataxia. Can. J. Neurol. Sci., 9, 185-188.
36. alb) mouse. Life Sci., 25, 2217-2221.
37. Messer, A., & Strominger, N. L. (1980). An allele of the mouse mutant dystonia musculorum exhibits lesions in red nucleus and striatum. Neuroscience, 5, 543-549.
38. 3H]GBR-12935 binding proteins. Arch. Biochem. Biophys., 276, 424-432.
39. Pascual, J., Pazos, A., del Olmo, E., Figols, J., Leno, C., & Berciano, J. (1991). Presynaptic parkinsonism in olivopontocerebellar atrophy: clinical, pathological, and neurochemical evidence. Ann. Neurol., 30, 425-428.
40. Perciavalle, V., Berretta, S., & Raffaele, R. (1989). Projections from the intracerebellar nuclei to the ventral midbrain tegmentum in the rat. Neurosci., 29, 109-119.
41. Petersen, P. L., Saad, J., & Nigro, M. A. (1988). The treatment of Friedreich's ataxia with amantadine hydrochloride. Neurology, 38, 1478-1480.
42. 3H]GBR 12935 binding. Mol. Pharmacol., 45, 125-135.
43. Pullara, J. M., & Marshall, J. F. (1989), Striatal dopamine innervation and receptor density: regional effect of the weaver mutation. Brain Res., 480, 225-233.
44. Richter, J. A., Stotz, E. H., Ghetti, B., & Simon, J. R. (1992). Comparison of alterations in tyroxine hydroxylase, dopamine levels, and dopamine uptake in the striatum of the weaver mutant mouse. Neurochem. Res., 17, 437-441.
45. Roffler-Tarlov, S., & Graybiel, A. M. (1984). Weaver mutation has differential effects on the dopamine-containing innervation of the and nonlimbic striatum. Nature, 307, 62-66.
46. Roffler-Tarlov, S., & Graybiel, A.M. (1986). Expressions of the weaver gene in dopamine-containing neural systems is dose-dependent and affects both striatal and nonstriatal regions. J. Neurosci., 6, 3319-3330.
47. Roffler-Tarlov, S., Pugatch, D., & Graybiel, A. M. (1990). Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. II. High affinity uptake sites for dopamine. J. Neurosci., 10, 734-740.
48. Scheffel, U., Dannals, R. F., Wong, D. F., Yokoi, F., Carroll, F. I., & Kuhar, M. J. (1992). Dopamine transporter imaging with novel, selective cocaine analogs. Neuroreport, 3, 969-972.
49. Schmidt, M. J., Sawyer, B. D., Perry, K. W., Fuller, R. W., Foreman, M. M., & Ghetti, B. (1982). Dopamine deficiency in the weaver mutant mouse. J. Neurosci., 2, 376-380.
50. Sidman, R. L., Green, M. C., & Appel, S. H. (1965). Catalog of the Neurological Mutants of the Mouse, pp. 66-67. Harvard University Press, Cambridge, MA.
51. Snider, R. S., Maiti, A., & Snider, S. R. (1976). Cerebellar pathways to ventral midbrain and nigra. Exper. Neurol., 53, 714-728.
52. Snyder, S. H. (1970). Putative neurotransmitter in the brain: selective neuronal uptake, subcellular localization and interactions with centrally acting drugs. Biol. Psychiat., 2, 367-389.
53. 125I]RTI-121. Synapse, 21, 364-372.
54. Stotz, E. H., Palacios, J. M., Landwehrmeyer, B., Norton, J., Ghetti, B., Simon, J. R., & Triarhou, L. C. (1994). Alterations in dopamine and serotonin uptake systems in the striatum of the weaver mutant mouse. J. Neural Transm., 97, 51-64.
55. 3H]citalopram quantitative autoradiography. J. Chem. Neuroanat., 10, 157-171.
56. Triarhou, L. C., Norton, J., & Ghetti, B. (1988). Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Exp. Brain Res., 70, 256-265.
57. Von Voigtlander, P., & Moore, K. (1970), Dopamine: release from the brain in vivo by amantadine. Science, 174, 408-410.
58. Vig, P. J. S., Desaiah, D., Joshi, P., Subramuny, S. H., Fratkin, J. D., & Currier, R. D. (1994). Decreased insulin-like growth factor I-mediated protein tyrosine phosphorylation in human olivopontocerebeilar atrophy and lurcher mutant mouse. J. Neurol. Sci., 124, 38-44.
59. Wüllner, U., Löschmann, P.-A., Weller, M., & Klockgether, T. (1995). Apoptotic cell death in the cerebellum of mutant weaver and lurcher mice. Neurosci. Lett., 200, 109-112.